Franz-Werner Haas, LLD, LLM
Chief Executive Officer
Franz-Werner Haas, LLD, LLM joined CureVac in June 2012. In August 2020, he has been appointed as Chief Executive Officer (CEO). Prior to his function as CEO, he was acting CEO as well as Chief Operating Officer (COO). In his position as COO, he was responsible for Human Resources, Intellectual Property, Legal and Operations. Before joining CureVac, he was Vice President Operations and Chief Compliance Officer of SYGNIS Pharma AG, where he was responsible for the execution of Merger&Acquisitions (M&A) and capital market transactions.
Dr. Haas started his professional career as an assistant to the management of a privately-held holding company before assuming several management positions in the Life Science Industry, including as Vice President and General Counsel of LION bioscience and General Counsel of Sirona Dental Systems. He studied law at the University of Saarbruecken, Catholic University of Leuven and the University of Edinburgh (LLM).